FLASH SALE! 50% Off PremiumSubscription Claim Offer ⏰ 0d 00h 00m 00s
AI Analysis AI Analysis of PRFX
Powered by GPT-4o
Stock Analysis
Risk Assessment
Trading Strategy
PDF

Red day on Tuesday for PainReform Ltd.
(Updated on Jan 21, 2025)

Sell candidate since Jan 08, 2025 Loss -5.68%

The PainReform Ltd. stock price fell by -0.99% on the last day (Tuesday, 21st Jan 2025) from $3.02 to $2.99. During the last trading day the stock fluctuated 5.52% from a day low at $2.90 to a day high of $3.06. The price has fallen in 7 of the last 10 days and is down by -9.94% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -82 thousand shares and in total, 45 thousand shares were bought and sold for approximately $133.81 thousand.

Given the current short-term trend, the stock is expected to rise 46.85% during the next 3 months and, with a 90% probability hold a price between $4.39 and $18.23 at the end of this 3-month period.

Investment opportunities can be found at any hour. So, react immediately to market-moving news and capture more market opportunities when convenient for you. You can trade over 10,000 US Stocks and ETFs, US Equity Index options, US Treasuries – and more - around the clock. Interactive Brokers’ dual market centers ensure reliable and dependable overnight trading on your timetable. (Member SIPC)

PRFX Signals & Forecast

There are mixed signals in the stock today. The PainReform Ltd. stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $3.51. On a fall, the stock will find some support from the short-term average at $2.98. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. A sell signal was issued from a pivot top point on Thursday, December 19, 2024, and so far it has fallen -73.21%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell along with the price during the last trading day, which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk.

Support, Risk & Stop-loss for PainReform Ltd. stock

PainReform Ltd. finds support from accumulated volume at $2.97 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move very much during the day (volatility) and with periodic low trading volume this stock is considered to be "very high risk". During the last day, the stock moved $0.160 between high and low, or 5.52%. For the last week the stock has had daily average volatility of 8.72%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (PRFX) For The Upcoming Trading Day Of Wednesday 22nd

For the upcoming trading day on Wednesday, 22nd we expect PainReform Ltd. to open at $2.98, and during the day (based on 14 day Average True Range), to move between $2.19 and $3.79, which gives a possible trading interval of +/-$0.80 (+/-26.80%) up or down from last closing price. If PainReform Ltd. takes out the full calculated possible swing range there will be an estimated 53.60% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $2.97 (0.67%) than the resistance at $3.20 (7.02%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is PainReform Ltd. stock A Buy?

PainReform Ltd. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

Current score: -2.376 Sell Candidate Unchanged

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

Predicted Fair Opening Price

Predicted fair opening price on January 22, 2025 - $2.98 ( 0.223%).

PRFX Performance

Trading levels for PRFX

Fibonacci Support & Resistance Levels

Level Price
R3 3.14 5.13%
R2 3.08 3.08%
R1 3.04 1.82%
Price 2.99
S1 2.92 -2.27%
S2 2.88 -3.53%
S3 2.82 -5.57%

Accumulated Volume Support & Resistance Levels

Level Price
R3 3.50 17.06%
R2 3.35 12.04%
R1 3.20 7.02%
Price 2.99
S1 2.97 -0.669%
S2 2.85 -4.68%
S3 2.78 -7.02%

FAQ

What is the symbol for PainReform Ltd. Stock and on which exchange is it traded?
The symbol for PainReform Ltd. is PRFX and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell PainReform Ltd. Stock?
PainReform Ltd. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

How to buy PainReform Ltd. Stock?
PainReform Ltd. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy PainReform Ltd. Stock.

What's the current price of PainReform Ltd. Stock?
As of the end of day on the Jan 21, 2025, the price of an PainReform Ltd. (PRFX) share was $2.99.

What is the 52-week high and low for PainReform Ltd. Stock?
The 52-week high for PainReform Ltd. Stock is $16.63 and the 52-week low is $0.196.

What is the market capitalization of PainReform Ltd. Stock?
As of the Jan 21, 2025, the market capitalization of PainReform Ltd. is 2.642M.

When is the next earnings date for PainReform Ltd.?
The upcoming earnings date for PainReform Ltd. is Feb 27, 2025.
Click to get the best stock tips daily for free!
ABOUT PAINREFORM LTD.
PainReform Ltd.
PainReform Ltd., a clinical stage specialty pharmaceutical company, engages in the development of therapeutics that provides an extended period of post-surgical pain relief in Israel. It engages in developing PRF-110, a viscous clear oil-based solution that is instilled directly into the surgical wound to provide localized and extended post-operative analgesia. The company is currently conducting two Phase 3 clinical trials of PRF-110 for the tre...
GOLDEN STAR
Ticker Change Signal Date
H
HYLS
$41.55
0.289% Jan 15
ROIC
$17.41
0.230% Jan 15
V
VGSH
$58.23
0.0515% Jan 15
F
FALN
$26.87
0.447% Jan 15
F
FTSM
$59.87
0.0668% Jan 15

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE